Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

People

Allergan Opens R&D Center In New Jersey

by Michael McCoy
September 10, 2012 | A version of this story appeared in Volume 90, Issue 37

[+]Enlarge
Credit: Allergan
Pyott speaking at the opening of Allergan’s New Jersey R&D center.
This is a photo of CEO David E.I. Pyott speaking at the opening of Allergan’s New Jersey R&D center.
Credit: Allergan
Pyott speaking at the opening of Allergan’s New Jersey R&D center.

Allergan has opened an R&D center in Bridgewater, N.J., that it says will eventually house several hundred employees. The California-based health care firm says the center will focus on clinical development. Allergan’s decision to open the lab contrasts with lab closings in New Jersey by drug companies such as Roche, Merck & Co., and Pfizer. Allergan CEO David E. I. Pyott told guests who gathered for an opening event that his firm expects to spend more than $1 billion on R&D in 2013.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.